Cyanocobalamin (Oral)
generics (over-the-counter Vitamin B12 tablets)
- Dosage form
- Tablet
- Available strengths
- Various: 50 mcg to 1000 mcg (some products up to 2500 mcg) tablets
- Drug class
- Vitamin (water-soluble B-complex, hematinic)
- Common brand
- generics (over-the-counter Vitamin B12 tablets)
Clinical overview. Oral cyanocobalamin is a synthetic, water-soluble form of vitamin B12 available over the counter in a wide range of tablet strengths. Current evidence, including a 2018 Cochrane review and the 2024 NICE guideline on vitamin B12 deficiency, supports high-dose oral cyanocobalamin (1000-2000 mcg daily) as an effective alternative to intramuscular injection for most patients, including many with malabsorption, provided adherence and follow-up monitoring are ensured.
Indication
Common therapeutic uses
- Treatment of vitamin B12 deficiency due to dietary insufficiency (e.g., strict vegan diet).
- Treatment of vitamin B12 deficiency due to malabsorption, including pernicious anemia, when given at high oral doses — passive, intrinsic-factor-independent absorption of about 1-2% of an oral dose is enough to meet requirements when the dose is high enough (1000-2000 mcg daily).
- Maintenance therapy following initial correction of vitamin B12 deficiency by any route.
Pregnancy
Risk assessment and monitoring considerations
- No adverse effects reported with normal daily requirement doses; untreated deficiency itself can be harmful, so replacement is continued when clinically indicated.
Breastfeeding
Infant exposure considerations
- Compatible with breastfeeding; vitamin B12 passes into breast milk at concentrations that approximate maternal blood levels.
Geriatrics
Dosing and tolerability considerations
- Vitamin B12 deficiency is common in older adults, often from reduced stomach acid or reduced intrinsic factor; oral high-dose therapy is effective in this population and avoids the burden of regular injections, provided adherence can be ensured.
Pediatrics
Use in children and adolescents
- Vitamin B12 deficiency in children is treated using the same principles as in adults, with dosing guided by blood counts and vitamin B12 levels under specialist direction.
Dosage & Administration
Practical dosing and administration
- High-dose oral regimen: 1000-2000 mcg daily until hematologic and biochemical normalization, then step down to a maintenance dose (e.g., 1000 mcg daily, or per current guideline-directed maintenance dosing).
- An alternative stepped maintenance schedule sometimes used: 1000 mcg daily, then 1000 mcg weekly, then 1000 mcg monthly.
- Reserve intramuscular/subcutaneous therapy (see the Vitamin B12 injection monograph) for patients with severe neurologic deficits requiring the fastest possible correction, confirmed nonadherence to oral therapy, or an inability to reliably follow up for monitoring.
- Monitor hemoglobin and vitamin B12 level response; ensure the patient is not concurrently vitamin B12 and folate deficient, and address any concurrent folate deficiency at the same time.
Overdose
Recognizing and responding to overdose
If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.
- Vitamin B12 is essentially nontoxic even at large oral doses; excess is not toxic and is excreted renally.
Common side effects
Frequently reported tolerability concerns
- Mild GI upset, headache — generally uncommon.
Serious side effects
Findings that may require urgent assessment
Serious side effects require immediate discussion with the prescriber or emergency care.
- Severe allergic reactions to oral cyanocobalamin are rare but have been reported; true hypersensitivity to cobalamins may require specialist input regardless of route.
Use with caution
Situations requiring closer assessment
- Use with caution when B12 deficiency has been present for more than 3 months with neurologic symptoms — do not delay starting therapy while confirming the optimal route; neurologic deficits may become permanent if correction is delayed.
- Confirm adherence and arrange follow-up monitoring before relying on oral therapy in a patient where adherence is uncertain.
Contraindications
Situations where therapy may be inappropriate
- Known hypersensitivity to cobalamins or cobalt.
Drug interactions
Clinically relevant combinations
- Absorption may be reduced by anticonvulsants (phenytoin, phenobarbital, primidone), colchicine, metformin, neomycin, and proton pump inhibitors/H2-receptor antagonists (via reduced gastric acid, relevant to food-bound B12 more than to high-dose supplement absorption, which is largely passive).
- High doses of vitamin C taken close in time to an oral B12 dose may reduce B12 bioavailability — separate administration when possible.
Food interactions
Meal-related administration
- Can be taken with or without food; food-bound B12 absorption (via intrinsic factor) is a separate pathway from the passive absorption relied upon at high supplemental doses.
Time of administration
Practical scheduling
- Once daily, any time of day; a consistent daily time supports adherence.
Storage
Product handling
- Store at room temperature, protected from light and moisture.
Patient take-away
Key counselling points for a quick closing summary
- High-dose oral B12 tablets work for most people with B12 deficiency, including many with pernicious anemia or other malabsorption — you do not automatically need injections.
- Taking your dose every day, exactly as directed, matters more with oral therapy than with injections, since missed doses have a bigger effect on your levels.
- Attend follow-up blood tests so your pharmacist or prescriber can confirm the oral dose is working for you.
References
Source material and product information
For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.